Form 4 for MNKD MANNKIND CORP
Accepted 2026-07-17 21:47:08 ET · period of report 2026-07-15 · accession 0001193125-26-308137 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 21:47 | 2026-07-15 | MNKD | Marasco Dominic | Pres, Endocrine Business Unit | F - Tax | $4.09 | -3,623 | 343.4K | -1% | -$14.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 Par Value | 2026-07-15 | F | D | 3,623 | $4.09 | 343,398 | D | — | — | (F1) Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units. (F2) Includes 2,775 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026. |